Gregory Russell, MS
Director of Design and Analysis Unit
Department of Biostatistical Sciences
and Bioinformatics Shared Resource
Forest University School of Medicine
Medical Center Blvd.
Winston-Salem, NC 27157
Tel: (336) 716-5449
UNC - Chapel Hill, School of Public Health – M.S.,
North Carolina State University – B.S., Statistics
- Cancer research
effects of disease
Russell received his M.S. in Biostatistics from the School of Public Health at
the University of North Carolina at Chapel Hill (UNC) in 1990. He has
experience in analysis of both large and small datasets; in addition to
analyzing the National Longitudinal Mortality Study for the effect of social
status as a contributing factor to the stroke belt region of the United States,
Mr. Russell has worked on numerous small trials for medical school investigators.
Over the past 24 years, he has worked with the Comprehensive Cancer
Center on a number of projects, looking at the effects of invasive surgery on
outcomes (including survival and quality of life); his work with the Center has
ranged from study inception and design through manuscript writing and
publication. For the past 20 years, he has worked with the Department of
Nephrology, investigating predictors of progression of diabetic kidney
disease. He is currently the Associate Director for the Design and
Analysis Unit (DAU), a component of the School’s Biomedical Research Services
and Administration. Through the DAU, Mr.
Russell provides services tailored to the
investigators’ needs, including assistance with hypothesis development, choice
of statistical methods, sample size estimation, and writing the statistical
sections of applications.
Selected Recent Publications
- Sirintrapun SJ, Blackham AU, Russell G, Votanopoulos K, Stewart JH, Shen P,
Levine EA, Geisinger KR, Bergman S. Significance
of signet ring cells in high-grade mucinous adenocarcinoma of the peritoneum
from appendiceal origin. Hum Pathol. 2014 Aug;45(8):1597-604. PMCID: PMC4107056.
- Blackham AU, Russell GB,
Stewart JH 4th, Votanopoulos K, Levine EA, Shen P. Metastatic colorectal cancer: survival
comparison of hepatic resection versus cytoreductive surgery and hyperthermic
Ann Surg Oncol. 2014 Aug;21(8):2667-74. PMCID: PMC4083005.
- Levine EA, Stewart JH 4th, Shen P, Russell GB, Loggie BL, Votanopoulos KI. Intraperitoneal chemotherapy for peritoneal
surface malignancy: experience with 1,000 patients. J Am Coll Surg. 2014
Apr;218(4):573-85. PMCID: PMC3965636.
- Duckworth KE, Forti AM, Russell
GB, Naik S, Hurd DD, McQuellon RP. Hematopoietic
stem cell transplant candidate and designated proxy distress levels prior to
hematopoietic stem cell transplantation.
Am J Hosp Palliat Care. 2014 Dec;31(8):853-6. PMCID: PMC4000744.
- Beisswenger PJ, Howell SK, Russell G, Miller ME, Rich SS, Mauer M. Detection of diabetic nephropathy from
advanced glycation endproducts (AGEs) differs in plasma and urine, and is
dependent on the method of preparation.
Amino Acids. 2014 Feb;46(2):311-9. PMID: 24036985.
- Duckworth KE, Forti AM, Russell GB, Naik S, Hurd D, McQuellon
RP. The process of advance care planning
in HCT candidates and proxies: self-efficacy, locus of control, and anxiety
levels. Am J Hosp
Palliat Care. 2014 Nov;31(7):710-6. PMCID: PMC3923853.
E, Russell G, Tedeschi R, Levine E, Shen P, Stewart J, Danhauer S,
Duckworth K, McQuellon R. Post-traumatic
growth is sustained two years after cytoreductive surgery plus hyperthermic
intraperitoneal chemotherapy [abstract]. Psychooncology. 2013; 22(Suppl 2):54.
PJ, Howell SK, Russell GB, Miller ME, Rich SS, Mauer M. Early progression of diabetic nephropathy
correlates with methylglyoxal-derived advanced glycation end products. Diabetes
36(10):3234-3239. PMCID: PMC3781566.
SC, Russell GB, Tedeschi RG, Jesse MT, Vishnevsky T, Daley K, Carroll S,
Triplett KN, Calhoun LG, Cann A, Powell BL. A longitudinal investigation of posttraumatic
growth in adult patients undergoing treatment for acute leukemia. J Clin Psychol Med Settings. 2013; 20(1):13-24. PMCID: PMC3790319.